In the last trading session, 3.07 million Agilon Health Inc (NYSE:AGL) shares changed hands as the company’s beta touched 0.53. With the company’s per share price at $2.98 changed hands at -$0.32 or -9.70% during last session, the market valuation stood at $1.23B. AGL’s last price was a discount, traded about -569.13% off its 52-week high of $19.94. The share price had its 52-week low at $2.99, which suggests the last value was -0.34% down since then. When we look at Agilon Health Inc’s average trading volume, we note the 10-day average is 3.67 million shares, with the 3-month average coming to 4.30 million.
Analysts gave the Agilon Health Inc (AGL) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.63. If we narrow down to specifics, the data shows that 0 out of 10 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 3 recommended AGL as a Hold, 7 felt it is a Buy and 0 rated the stock as Underweight. Agilon Health Inc’s EPS for the current quarter is expected to be -0.11.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Agilon Health Inc (NYSE:AGL) trade information
Instantly AGL was in red as seen at the end of in last trading. With action -7.45%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -76.25%, with the 5-day performance at -7.45% in the red. However, in the 30-day time frame, Agilon Health Inc (NYSE:AGL) is -23.00% down. Looking at the short shares, we see there were 36.49 million shares sold at short interest cover period of 7.68 days.
The consensus price target for the stock as assigned by Wall Street analysts is 5, meaning bulls need an upside of 40.4% from its current market value. According to analyst projections, AGL’s forecast low is 3 with 6.5 as the target high. To hit the forecast high, the stock’s price needs a -118.12% plunge from its current level, while the stock would need to soar -0.67% for it to hit the projected low.
Agilon Health Inc (AGL) estimates and forecasts
Data shows that the Agilon Health Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -45.42% over the past 6 months, a 15.22% in annual growth rate that is considerably higher than the industry average of 7.30%. Year-over-year growth is forecast to reach 39.60% up from the last financial year.
Consensus estimates given by 18 financial analysts project the company’s revenue in the current quarter to hit an average of 1.47B. 18 analysts are of the opinion that Agilon Health Inc’s revenue for the current quarter will be 1.47B. The company’s revenue for the corresponding quarters a year ago was 1.22B and 1.06B respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 21.00%. The estimates for the next quarter sales put growth at 38.90%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 7.65%. The 2024 estimates are for Agilon Health Inc earnings to increase by 25.75%.
AGL Dividends
Agilon Health Inc is expected to release its next quarterly earnings report on 2024-Nov-07.
Agilon Health Inc (NYSE:AGL)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 1.79% of Agilon Health Inc shares while 111.46% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 113.49%. There are 111.46% institutions holding the Agilon Health Inc stock share, with CLAYTON, DUBILIER & RICE, LLC the top institutional holder. As of 2024-06-30, the company held 24.3149% of the shares, roughly 100.0 million AGL shares worth $654.0 million.
FMR LLC holds the second largest percentage of outstanding shares, with 13.8418% or 56.93 million shares worth $372.3 million as of 2024-06-30.
Among Mutual Funds, the top two as of Jul 31, 2024 were Vanguard Specialized-Health Care Fund and Smallcap World Fund . With 34.72 shares estimated at $103.47 million under it, the former controlled 8.44% of total outstanding shares. On the other hand, Smallcap World Fund held about 6.33% of the shares, roughly 26.06 shares worth around $77.64 million.
